Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
NRx Pharmaceuticals, Inc. NRXPW
$0.15
-$0.01 (-6.25%)
На 18:01, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
10591901.00000000
-
week52high
0.15
-
week52low
0.15
-
Revenue
0
-
P/E TTM
0
-
Beta
0.96782000
-
EPS
-6.24700000
-
Last Dividend
0.00000000
-
Next Earnings Date
07 мая 2023 г. в 02:06
Описание компании
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics for the treatment of bipolar depression in patients with acute suicidal behavior/ideation and sub-acute suicidal ideation and behavior. The company was founded in 2015 and is based in Wilmington, Delaware.
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Willard Stephen H | A | 50000 | 50000 | 16 дек 2022 г. |
| VAN VOORHEES SETH | A | 46337 | 30000 | 16 дек 2022 г. |
| Javitt Jonathan C | D | 12899997 | 400000 | 07 дек 2022 г. |
| Javitt Daniel C. | D | 9634793 | 8441 | 30 ноя 2022 г. |
| Javitt Daniel C. | D | 9643234 | 13730 | 29 ноя 2022 г. |
| Flynn Patrick John | A | 1750 | 1750 | 28 ноя 2022 г. |
| Flynn Patrick John | A | 40209 | 2500 | 28 ноя 2022 г. |
| Flynn Patrick John | A | 37709 | 2500 | 28 ноя 2022 г. |
| VAN VOORHEES SETH | A | 16337 | 7021 | 25 ноя 2022 г. |
| VAN VOORHEES SETH | A | 9316 | 600 | 25 ноя 2022 г. |
Свежие комментарии
Свежие комментарии